TARA
Protara Therapeutics Inc
3.40$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 9.04 | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.15 | 0.07 | – | 0.14 | 0.30 | 0.34 | 0.04 | 0.00 | 0.03 | 0.10 | 0.02 | 0.03 | 0.02 | 0.01 | |
| -0.15 | -0.07 | 9.04 | -0.14 | -0.30 | -0.34 | -0.04 | 0.00 | -0.03 | -0.10 | -0.02 | -0.03 | -0.02 | -0.01 | |
| 15.76 | 10.66 | 19.72 | 30.08 | 45.57 | 50.22 | 6.06 | 1.58 | 1.64 | 1.88 | 1.49 | 2.19 | 1.54 | 1.00 | |
| – | – | 12.56 | 20.62 | 23.76 | 0.25 | 4.13 | 2.17 | 3.11 | 2.35 | 1.84 | 1.64 | 0.85 | 0.51 | |
| 21.18 | 18.93 | 32.27 | 50.57 | 69.03 | 69.96 | 10.19 | 3.75 | 4.73 | 4.23 | 5.96 | 3.82 | 2.39 | 1.50 | |
| -21.33 | -19.00 | -23.24 | -50.70 | -69.33 | -70.31 | -10.19 | -3.75 | -4.76 | -4.23 | -5.96 | -3.85 | -2.39 | -1.51 | |
| – | 2.30 | 2.63 | 0.35 | 0.47 | 0.60 | 0.00 | 0.00 | 0.00 | 0.15 | 0.10 | – | 0.20 | – | |
| -21.26 | -21.11 | -10.24 | -51.94 | -68.90 | -69.38 | -9.93 | -3.69 | -4.70 | -4.21 | -5.86 | -3.57 | -2.17 | -1.34 | |
| – | – | 15.62 | -0.88 | 0.90 | 1.52 | 2.09 | -0.06 | -0.06 | -0.01 | -0.10 | -0.03 | – | – | |
| -21.26 | -21.11 | -10.24 | -51.94 | -68.90 | -69.38 | -9.93 | -3.69 | -4.70 | -4.21 | -5.86 | -3.57 | -2.17 | -1.34 | |
| -21.11 | -18.74 | -7.53 | -51.80 | -68.60 | -69.04 | -8.05 | -1.92 | -4.67 | -4.04 | -5.73 | -3.54 | -2.15 | -1.33 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.